Literature DB >> 27511731

A Histone Methyltransferase ESET Is Critical for T Cell Development.

Shoichi Takikita1, Ryunosuke Muro1, Toshiyuki Takai2, Takeshi Otsubo3, Yuki I Kawamura3, Taeko Dohi3, Hiroyo Oda1, Masayuki Kitajima1, Kenshiro Oshima4, Masahira Hattori5, Takaho A Endo6, Tetsuro Toyoda6, John Weis7, Yoichi Shinkai8, Harumi Suzuki9.   

Abstract

ESET/SETDB1, one of the major histone methyltransferases, catalyzes histone 3 lysine 9 (H3K9) trimethylation. ESET is critical for suppressing expression of retroviral elements in embryonic stem cells; however, its role in the immune system is not known. We found that thymocyte-specific deletion of ESET caused impaired T cell development, with CD8 lineage cells being most severely affected. Increased apoptosis of CD8 single-positive cells was observed, and TCR-induced ERK activation was severely inhibited in ESET(-/-) thymocytes. Genome-wide comprehensive analysis of mRNA expression and H3K9 trimethylation revealed that ESET regulates expression of numerous genes in thymocytes. Among them, FcγRIIB, whose signaling can inhibit ERK activation, was strongly and ectopically expressed in ESET(-/-) thymocytes. Indeed, genetic depletion of FcγRIIB in ESET(-/-) thymocytes rescued impaired ERK activation and partially restored defective positive selection in ESET(-/-) mice. Therefore, impaired T cell development in ESET(-/-) mice is partly due to the aberrant expression of FcγRIIB. Collectively, to our knowledge, we identify ESET as the first trimethylated H3K9 histone methyltransferase playing a crucial role in T cell development.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27511731     DOI: 10.4049/jimmunol.1502486

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  ATF7IP regulates SETDB1 nuclear localization and increases its ubiquitination.

Authors:  Takeshi Tsusaka; Chikako Shimura; Yoichi Shinkai
Journal:  EMBO Rep       Date:  2019-10-02       Impact factor: 8.807

2.  Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.

Authors:  Shuhei Ueshima; Jia Fang
Journal:  Oncogene       Date:  2022-05-11       Impact factor: 9.867

Review 3.  Bivalent Regulation and Related Mechanisms of H3K4/27/9me3 in Stem Cells.

Authors:  Han Sun; Yin Wang; Ying Wang; Feng Ji; An Wang; Ming Yang; Xu He; Lisha Li
Journal:  Stem Cell Rev Rep       Date:  2021-08-21       Impact factor: 5.739

Review 4.  Role of Epigenetics in the Regulation of Immune Functions of the Skin.

Authors:  Yu Sawada; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2020-11-27       Impact factor: 8.551

5.  ATF7ip Targets Transposable Elements for H3K9me3 Deposition to Modify CD8+ T Cell Effector and Memory Responses.

Authors:  Jun Hyung Sin; Sujit Kashyap; Dante Acenas; Jessica T Cortez; James Lee; Alexander Marson; Mehrdad Matloubian; Michael R Waterfield
Journal:  J Immunol       Date:  2022-02-02       Impact factor: 5.422

6.  A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing.

Authors:  Masaki Kato; Keiko Takemoto; Yoichi Shinkai
Journal:  Nat Commun       Date:  2018-04-27       Impact factor: 14.919

Review 7.  Control of Intra-Thymic αβ T Cell Selection and Maturation by H3K27 Methylation and Demethylation.

Authors:  Rémy Bosselut
Journal:  Front Immunol       Date:  2019-04-03       Impact factor: 7.561

Review 8.  SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis.

Authors:  Jacob Batham; Pek Siew Lim; Sudha Rao
Journal:  Cancers (Basel)       Date:  2019-08-09       Impact factor: 6.639

Review 9.  SETDB1 in cancer: overexpression and its therapeutic implications.

Authors:  Vanessa J Lazaro-Camp; Kiarash Salari; Xiangbing Meng; Shujie Yang
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  LncRNA HOTAIR promotes cell migration and invasion by regulating MKL1 via inhibition miR206 expression in HeLa cells.

Authors:  Peng Zheng; Ze Yin; Ying Wu; Yao Xu; Ying Luo; Tong-Cun Zhang
Journal:  Cell Commun Signal       Date:  2018-02-01       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.